1. Home
  2. A vs BDX Comparison

A vs BDX Comparison

Compare A & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$130.56

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Logo Becton Dickinson and Company

BDX

Becton Dickinson and Company

HOLD

Current Price

$145.52

Market Cap

40.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
A
BDX
Founded
1999
1897
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8B
40.3B
IPO Year
1999
1997

Fundamental Metrics

Financial Performance
Metric
A
BDX
Price
$130.56
$145.52
Analyst Decision
Strong Buy
Buy
Analyst Count
15
13
Target Price
$161.47
$186.00
AVG Volume (30 Days)
2.4M
2.3M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
0.92%
2.89%
EPS Growth
3.16
N/A
EPS
2.27
0.25
Revenue
$4,472,000,000.00
$21,840,000,000.00
Revenue This Year
$8.45
N/A
Revenue Next Year
$6.13
$3.02
P/E Ratio
$57.19
$584.96
Revenue Growth
6.43
8.24
52 Week Low
$108.35
$141.82
52 Week High
$160.27
$213.08

Technical Indicators

Market Signals
Indicator
A
BDX
Relative Strength Index (RSI) 57.01 45.41
Support Level $121.63 $142.48
Resistance Level $140.68 $153.09
Average True Range (ATR) 4.17 3.20
MACD -0.39 0.16
Stochastic Oscillator 58.53 29.97

Price Performance

Historical Comparison
A
BDX

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About BDX Becton Dickinson and Company

Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.

Share on Social Networks: